Intracerebral delivery of Carboplatin in combination with either 6 MV Photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Bobyk, Laure ^a,b,c   Edouard, Magali ^a,c   Deman, Pierre ^a,c   Rousseau, Julia ^a,c   Adam, Jean François ^a,c,e   Ravanat, Jean Luc ^b   Estève, François ^a,c,e   Balosso, Jacques ^a,c,e   Barth, Rolf F ^d   Elleaume, Hélène ^a,c,e  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b CEA GRENOBLE   (France)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIV GRENOBLE ALPES   (France)

Author keywords

Carboplatin; F98 rat glioma; Intracerebral delivery; Osmotic pumps; Radiotherapy with 6 MV photons or synchrotron X rays

Indexed keywords

CARBOPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFICACY; GLIOMA; MALE; MONOTHERAPY; NONHUMAN; OSMOTIC PUMP; PHOTON; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RAT; SURVIVAL TIME; SYNCHROTRON RADIATION; X IRRADIATION;

ANIMALS; BRAIN NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; GLIOMA; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASMS, EXPERIMENTAL; PHOTONS; RATS; SYNCHROTRONS; X-RAY THERAPY;

EID: 84866499498     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-78     Document Type: Article

References (39)

1. Absorbed dose in the presence of contrast agents during pediatric cardiac catheterization. Callisen HH, Norman A, Adams FH, Med Phys 1979 6 504 509 545120 (Pubitemid 10185593)
2. Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours. Boudou C, Balosso J, Esteve F, Elleaume H, Phys Med Biol 2005 50 4841 4851 10.1088/0031-9155/50/20/007 16204876 (Pubitemid 41417007)
3. Synchrotron stereotactic radiotherapy: dosimetry by Fricke gel and Monte Carlo simulations. Boudou C, Biston MC, Corde S, Adam JF, Ferrero C, Esteve F, Elleaume H, Phys Med Biol 2004 49 5135 5144 10.1088/0031-9155/49/22/008 15609563 (Pubitemid 39585548)
4. Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements. Boudou C, Tropres I, Rousseau J, Lamalle L, Adam JF, Esteve F, Elleaume H, Phys Med Biol 2007 52 4881 4892 10.1088/0031-9155/52/16/011 17671341 (Pubitemid 47232293)
5. Normoxic polyacrylamide gel doped with iodine: response versus X-ray energy. Gastaldo J, Boudou C, Lamalle L, Tropres I, Corde S, Sollier A, Rucka G, Elleaume H, Eur J Radiol 2008 68 118 120 10.1016/j.ejrad.2008.04.053 18602237
6. Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents. Mesa AV, Norman A, Solberg TD, Demarco JJ, Smathers JB, Phys Med Biol 1999 44 1955 1968 10.1088/0031-9155/44/8/308 10473207 (Pubitemid 29387604)
7. Synchrotron Radiation Therapy from a Medical Physics point of view. Prezado Y, Adam JF, Berkvens P, Martinez-Rovira I, Fois G, Thengumpallil S, Edouard M, Vautrin M, Deman P, Brauer-Krisch E, et al. In 6th International Conference on Medical Applications of Synchrotron Radiation. Volume 1266. Edited by Siu KKW. 101-106. AIP Conference Proceedings
8. Biological equivalent dose studies for dose escalation in the stereotactic synchrotron radiation therapy clinical trials. Prezado Y, Fois G, Edouard M, Nemoz C, Renier M, Requardt H, Esteve F, Adam JF, Elleaume H, Bravin A, Med Phys 2009 36 725 733 10.1118/1.3070538 19378733
9. Tumour dose enhancement using modified megavoltage photon beams and contrast media. Robar JL, Riccio SA, Martin MA, Phys Med Biol 2002 47 2433 2449 10.1088/0031-9155/47/14/305 12171332 (Pubitemid 34823321)
10. Iodinated contrast agents for brain tumor localization and radiation dose enhancement. Norman A, Iwamoto KS, Cochran ST, Invest Radiol 1991 26 Suppl 1 120 121 discussion S125-128 1808106
11. Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Rousseau J, Boudou C, Barth RF, Balosso J, Esteve F, Elleaume H, Clin Cancer Res 2007 13 5195 5201 10.1158/1078-0432.CCR-07-1002 17726137 (Pubitemid 47502089)
12. Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats. Rousseau J, Barth RF, Moeschberger ML, Elleaume H, Int J Radiat Oncol Biol Phys 2009 73 530 536 10.1016/j.ijrobp.2008.09.018 19147017
13. Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. Rousseau J, Barth RF, Fernandez M, Adam JF, Balosso J, Esteve F, Elleaume H, J Neurooncol 2010 98 287 295 10.1007/s11060-009-0074-3 20012464
14. Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H, J Neurooncol 2011 101 379 390 10.1007/s11060-010-0272-z 20577779
15. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. Go RS, Adjei AA, J Clin Oncol 1999 17 409 422 10458260 (Pubitemid 29022420)
16. A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin. Hongo A, Seki S, Akiyama K, Kudo T, Int J Biochem 1994 26 1009 1016 10.1016/0020-711X(94)90072-8 8088411
17. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato) platinum(II) differ only in the kinetics of their interaction with DNA. Knox RJ, Friedlos F, Lydall DA, Roberts JJ, Cancer Res 1986 46 1972 1979 3512077 (Pubitemid 16080411)
18. New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, DiMeco F, Clatterbuck RE, Olivi A, Guarnieri M, J Neurooncol 2002 60 151 158 10.1023/A:1020626419269 12635662 (Pubitemid 35291238)
19. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR, J Neurosurg 2003 99 893 898 10.3171/jns.2003.99.5.0893 14609170 (Pubitemid 37314926)
20. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Olivi A, Ewend MG, Utsuki T, Tyler B, Domb AJ, Brat DJ, Brem H, Cancer Chemother Pharmacol 1996 39 90 96 10.1007/s002800050542 8995504 (Pubitemid 26400665)
21. Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study. Olivi A, Gilbert M, Duncan KL, Corden B, Lenartz D, Brem H, Cancer Chemother Pharmacol 1993 31 449 454 10.1007/BF00685034 8453683 (Pubitemid 23093316)
22. Toxicity and cerebrospinal fluid levels of carboplatin chronically infused into the brainstem of a primate. Strege RJ, Liu YJ, Kiely A, Johnson RM, Gillis EM, Storm P, Carson BS, Jallo GI, Guarnieri M, J Neurooncol 2004 67 327 334 15164988 (Pubitemid 39137363)
23. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Biston MC, Joubert A, Adam JF, Elleaume H, Bohic S, Charvet AM, Esteve F, Foray N, Balosso J, Cancer Res 2004 64 2317 2323 10.1158/0008-5472.CAN-03-3600 15059878 (Pubitemid 38523880)
24. The role of atomic inner shell relaxations for photon-induced DNA damage. Bernhardt P, Friedland W, Paretzke HG, Radiat Environ Biophys 2004 43 77 84 15235795 (Pubitemid 39100938)
25. Radiation and platinum drug interaction. Nias AH, Int J Radiat Biol Related Stud Phys, Chem Med 1985 48 297 314 10.1080/09553008514551301 (Pubitemid 15232108)
26. Response to Dr. Nicholas Foray's commentary on the paper by Rousseau et al. entitled "Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors". Elleaume H, Rousseau J, Barth RF, Fernandez M, Adam JF, Esteve F, J Neuro-Oncol 2011 101 165 167 10.1007/s11060-010-0228-3
27. Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues. Guarnieri M, Carson BS, Khan A, Penno M, Jallo GI, J Neurosci Methods 2005 144 147 152 10.1016/j.jneumeth.2004. 10.019 15910972 (Pubitemid 40720139)
28. Infusion rates and drug distribution in brain tumor models in rats. Khan A, Jallo GI, Liu YJ, Carson BS Sr, Guarnieri M, J Neurosurg 2005 102 53 58 16206734 (Pubitemid 44955010)
29. Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways. Corde S, Balosso J, Elleaume H, Renier M, Joubert A, Biston MC, Adam JF, Charvet AM, Brochard T, Le Bas JF, et al. Cancer Res 2003 63 3221 3227 12810651 (Pubitemid 36735875)
30. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas. Adam JF, Elleaume H, Joubert A, Biston MC, Charvet AM, Balosso J, Le Bas JF, Esteve F, Int J Radiat Oncol Biol Phys 2003 57 1413 1426 10.1016/j.ijrobp.2003.07.007 14630281 (Pubitemid 37443984)
31. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Adam JF, Joubert A, Biston MC, Charvet AM, Peoc'h M, Le Bas JF, Balosso J, Esteve F, Elleaume H, Int J Radiat Oncol Biol Phys 2006 64 603 611 10.1016/j.ijrobp.2005.09.004 16338098 (Pubitemid 43083450)
32. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. Corde S, Joubert A, Adam JF, Charvet AM, Le Bas JF, Esteve F, Elleaume H, Balosso J, Br J Cancer 2004 91 544 551 10.1038/sj.bjc.6601951 15266326 (Pubitemid 39093577)
33. Anti-canceral therapy by gold nanoparticle photoactivation. Taupin F, Bobyk L, Delorme R, Ravanat JL, Elleaume H, Bulletin Du Cancer 98 80
34. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Cho SH, Jones BL, Krishnan S, Phys Med Biol 2009 54 4889 4905 10.1088/0031-9155/54/16/004 19636084
35. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. McMahon SJ, Mendenhall MH, Jain S, Currell F, Phys Med Biol 2008 53 5635 5651 10.1088/0031-9155/53/20/005 18812647
36. Enhancement of radiation effect by heavy elements. Kobayashi K, Usami N, Porcel E, Lacombe S, Le Sech C, Mutat Res 704 123 131
37. Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. Yang WL, Huo TY, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H, J Neuro-Oncol 2011 101 379 390 10.1007/s11060-010-0272-z
38. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Dale RG, Br J Radiol 1985 58 515 528 10.1259/0007-1285-58-690-515 4063711 (Pubitemid 15018411)
39. Letter: Fractionation schedules and a quadratic dose-effect relationship. Douglas BG, Fowler JF, Br J Radiol 1975 48 502 504 10.1259/0007-1285-48-570-502 1227709